UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The drugs that mostly frequently induce acute kidney injury: a case − noncase study of a pharmacovigilance database

British journal of clinical pharmacology, 2017-06, Vol.83 (6), p.1341-1349

2017

Volltextzugriff (PDF)

Postmarket safety profile of suicide/self-injury for GLP-1 receptor agonist: a real-world pharmacovigilance analysis

European psychiatry, 2023-11, Vol.66 (1), p.e99-e99, Article e99

2023

Volltextzugriff (PDF)

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

The New England journal of medicine, 2016-11, Vol.375 (18), p.1749-1755

2016

Volltextzugriff (PDF)

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

The European respiratory journal, 2019-12, Vol.54 (6), p.1901522

2019

Volltextzugriff (PDF)

Acute appendicitis in a patient immunised with COVID‐19 vaccine: A case report with morphological analysis

British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.551-555

2023

Volltextzugriff (PDF)

Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study

Rheumatology (Oxford, England), 2022-02, Vol.61 (2), p.865-867

2022

Volltextzugriff (PDF)

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database

Arthritis & rheumatology (Hoboken, N.J.), 2018-09, Vol.70 (9), p.1399-1407

2018

Volltextzugriff (PDF)

Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Frontiers in endocrinology (Lausanne), 2024-02, Vol.15, p.1330936-1330936

2024

Volltextzugriff (PDF)

Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy

JNCI : Journal of the National Cancer Institute, 2021-10, Vol.113 (10), p.1396-1404

2021

Volltextzugriff (PDF)

Cardiovascular Toxicities Associated With Ibrutinib

Journal of the American College of Cardiology, 2019-10, Vol.74 (13), p.1667-1678

2019

Volltextzugriff (PDF)

Immune Checkpoint Inhibitor–Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution

Circulation (New York, N.Y.), 2018-08, Vol.138 (7), p.743-745

2018

Volltextzugriff (PDF)

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study

British journal of clinical pharmacology, 2019-07, Vol.85 (7), p.1507-1515

2019

Volltextzugriff (PDF)

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

Annals of the rheumatic diseases, 2020-11, Vol.79 (11), p.1400-1413

2020

Volltextzugriff (PDF)

The process defines the product: what really matters in biosimilar design and production?

Rheumatology (Oxford, England), 2017-08, Vol.56 (suppl_4), p.iv14-iv29

2017

Volltextzugriff (PDF)

Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study

BMC health services research, 2015-07, Vol.15 (1), p.259-259, Article 259

2015

Volltextzugriff (PDF)

Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis

British journal of haematology, 2019-04, Vol.185 (2), p.297-310

2019

Volltextzugriff (PDF)

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Journal for immunotherapy of cancer, 2019-05, Vol.7 (1), p.134-9, Article 134

2019

Volltextzugriff (PDF)

Risk and Time-to-Onset of Acute Kidney Injury With Vancomycin Plus Piperacillin-tazobactam Combination: Analysis Using JADER

In vivo (Athens), 2024-05, Vol.38 (3), p.1436-1442

2024

Volltextzugriff (PDF)

Hematologic Complications of Immune Checkpoint Inhibitors

The oncologist (Dayton, Ohio), 2019-05, Vol.24 (5), p.584-588

2019

Volltextzugriff (PDF)

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

The international journal of neuropsychopharmacology, 2019-04, Vol.22 (4), p.270-277

2019

Volltextzugriff (PDF)

Impact of the U.S. Food and Drug Administration's Safety‐Related Announcements on the Use of Bisphosphonates After Hip Fracture

Journal of bone and mineral research, 2016-08, Vol.31 (8), p.1536-1540

2016

Volltextzugriff (PDF)

Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis

Allergy (Copenhagen), 2014-07, Vol.69 (7), p.954-959

2014

Volltextzugriff (PDF)

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib

Scientific reports, 2022-11, Vol.12 (1), p.20601-20601, Article 20601

2022

Volltextzugriff (PDF)

Call to action: Harmonization of pharmacovigilance regulations for post‐marketing pregnancy and breastfeeding safety studies

British journal of clinical pharmacology, 2024-03, Vol.90 (3), p.715-721

2024

Volltextzugriff (PDF)

1 – 25 von 655

Suche als RSS-Feed

Aktive Filter

KollektionFree E-Journal (出版社公開部分のみ）

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(633)
Mit Volltextzugriff
(617)

Publikationsform

Artikel
(655)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(648)
Pharmacovigilance
(646)
Science & Technology
(593)
Life Sciences & Biomedicine
(518)
Male
(518)
Adult
(363)
Middle Aged
(351)
Aged
(280)
Young Adult
(164)
Adolescent
(162)
Pharmacology & Pharmacy
(160)
Aged, 80 And Over
(120)
Drugs
(116)
Adverse Drug Reaction Reporting Systems
(112)
Patients
(112)
Risk Factors
(110)
Child
(107)
Retrospective Studies
(104)
Drug-Related Side Effects And Adverse Reactions - Epidemiology
(94)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The drugs that mostly frequently induce acute kidney injury: a case − noncase study of a pharmacovigilance database

Postmarket safety profile of suicide/self-injury for GLP-1 receptor agonist: a real-world pharmacovigilance analysis

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Acute appendicitis in a patient immunised with COVID‐19 vaccine: A case report with morphological analysis

Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database

Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy

Cardiovascular Toxicities Associated With Ibrutinib

A case report of clonal EBV-like memory CD4 + T cell activation in fatal checkpoint inhibitor-induced encephalitis

Immune Checkpoint Inhibitor–Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

The process defines the product: what really matters in biosimilar design and production?

Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study

Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Risk and Time-to-Onset of Acute Kidney Injury With Vancomycin Plus Piperacillin-tazobactam Combination: Analysis Using JADER

Hematologic Complications of Immune Checkpoint Inhibitors

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

Impact of the U.S. Food and Drug Administration's Safety‐Related Announcements on the Use of Bisphosphonates After Hip Fracture

Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib

Call to action: Harmonization of pharmacovigilance regulations for post‐marketing pregnancy and breastfeeding safety studies

Aktive Filter

Suchergebnisse filtern